Marc de Garidel

Insider Reports History

Location
Boston, MA
Signature
/s/ Amanda Gonzalez Burton, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc de Garidel:

Company Role Class Num Shares Value Price $ Report Date Ownership
CinCor Pharma, Inc. Chief Executive Officer, Director Common Stock 0 $28.75 24 Feb 2023 Direct
CinCor Pharma, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 $8.34 24 Feb 2023 Direct

Insider Reports Filed by Marc de Garidel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123012890-de-garidel-marc-2023-02-24 CinCor Pharma, Inc. 24 Feb 2023 4 $0 4 Chief Executive Officer, Director 24 Feb 2023, 17:34
/report/000120919123005596-de-garidel-marc-2023-01-26 CinCor Pharma, Inc. 26 Jan 2023 1 $0 4 Chief Executive Officer, Director 30 Jan 2023, 19:08
/report/000120919122003186-de-garidel-marc-2022-01-11 CinCor Pharma, Inc. 11 Jan 2022 1 +$200,000 4 Chief Executive Officer, Director 13 Jan 2022, 15:26
/report/000120919122002273-de-garidel-marc-2022-01-06 CinCor Pharma, Inc. 06 Jan 2022 0 $0 3 Chief Executive Officer, Director 06 Jan 2022, 19:46